Konstantinos Fragkiadakis

Dr. Konstantinos Fragkiadakis

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
PIPetros Ioannou
Petros Ioannou
SPSymeon Panagiotakis
Symeon Panagiotakis
ETEmmanouela Tsagkaraki
Emmanouela Tsagkaraki
Constantinos TsioutisConstantinos Tsioutis
Constantinos Tsioutis
KFKonstantinos Fragkiadakis
Konstantinos Fragkiadakis
Theodosios D FilippatosTheodosios D Filippatos
Theodosios D Filippatos
Hyponatremia is the most common electrolyte disorder, commonly affecting older hospitalized individuals; however, the literature is not clear regarding its effect on mortality. The aim of this 2-year observational prospective cohort study was to evaluate the mortality and re-admission rates, the clinical and laboratory characteristics and the causes of hyponatremia in patients older than 65 years admitted with a corrected serum sodium of 130 mEq/L or less in an internal medicine ward of a tertiary Greek university hospital. During the observation period, 138 patients (mean age 80.5 years, 36.2% male) fulfilled the inclusion criteria and were prospectively followed for 1 year after admission. Symptoms of hyponatremia were present in 59.4% of patients. Hypovolemia was the main sole cause of hyponatremia, but in about one third of patients, hyponatremia was multifactorial. Only a low proportion of patients (12.3%) fulfilled the criteria of the syndrome of inappropriate antidiuresis (SIAD) at admission according to the current guidelines. The re-admission rates at 3- and 12-months following discharge was 34.2% and 51.8%, respectively. Mortality during hospitalization was 17.4% and was higher compared to non-hyponatremic admitted older patients, while the total mortality at 1 year after admission was 28.3%, indicating that hyponatremia at admission is a marker of significant mortality during and after hospitalization in elderly patients.

15 March 2021 in Genes
Verified
Journal Article
Open access
PDF file
Maria E. MarketouMaria E. Marketou
Maria E. Marketou
JKJoanna Kontaraki
Joanna Kontaraki
APAlexandros PAtrianakos
Alexandros PAtrianakos
GKGeorge Kochiadakis
George Kochiadakis
IAIoannis Anastasiou
Ioannis Anastasiou
FPFragiskos Parthenakis
Fragiskos Parthenakis
Background: microRNAs (miRs) have emerged as important modulators of cardiovascular development and disease. Our aim was to determine whether cardiac-related miRs such as miR-21-5p and miR-1-3p were differentially expressed in acute viral myocarditis and whether any of them was related with the extent of myocardial damage and left ventricular dysfunction. Methods: We enrolled 40 patients with acute viral myocarditis. Blood samples were taken on admission and miRs expression levels in peripheral blood mononuclear cells were quantified by real-time reverse transcription polymerase chain reaction. Results: miR-21-5p, miR-1-3p were significantly elevated in acute myocarditis. miR-21-5p levels showed a strong correlation with global longitudinal strain (r = 0.71, p < 0.01), while miR-1-3p had significant correlations with troponin I (r = 0.79, p < 0.01). Conclusions: The expression of miR-21-5p and miR-1-3p in peripheral blood is increased in acute viral myocarditis, and this increase is correlated with myocardial damage and indicative of left ventricular systolic dysfunction in these patients.

30 October 2018 in Journal of Human Hypertension
Verified
Journal Article
Closed access
PDF file
Maria E. MarketouMaria E. Marketou
Maria E. Marketou
JKJoanna Kontaraki
Joanna Kontaraki
JPJohn Papadakis
John Papadakis
GKGeorge Kochiadakis
George Kochiadakis
GVGeorge Vrentzos
George Vrentzos
FPFragiskos Parthenakis
Fragiskos Parthenakis

18 October 2024 in Journal of Human Hypertension
Verified
Journal Article
Closed access
PDF file
EAEleni Angelaki
Eleni Angelaki
Georgios D. BarmparisGeorgios D. Barmparis
Georgios D. Barmparis
KFKonstantinos Fragkiadakis
Konstantinos Fragkiadakis
SMSpyros Maragkoudakis
Spyros Maragkoudakis
EZEvangelos Zacharis
Evangelos Zacharis
Maria E. MarketouMaria E. Marketou
Maria E. Marketou

Verified
Journal Article
Open access
PDF file
VKVasiliki Katsi
Vasiliki Katsi
AAAngeliki Alifragki
Angeliki Alifragki
KFKonstantinos Fragkiadakis
Konstantinos Fragkiadakis
NKNikolaos Kopidakis
Nikolaos Kopidakis
EKELEFTHERIOS KALLERGIS
ELEFTHERIOS KALLERGIS
Maria E. MarketouMaria E. Marketou
Maria E. Marketou
Gestational complications, such as preeclampsia and gestational diabetes mellitus (GDM), pose significant risks to maternal and fetal health and increase long-term cardiovascular disease risk in offspring. This review aims to synthesize current knowledge on the roles of ferroptosis and neutrophil extracellular trap formation (NETosis)—two regulated cell death pathways—in these pregnancy-related conditions. We performed a comprehensive analysis of preclinical and clinical studies that investigate the involvement of dysregulated iron metabolism, oxidative stress, inflammation, and endothelial dysfunction mediated by ferroptosis and NETosis in gestational pathologies. Evidence indicates that disturbances in maternal iron homeostasis and enhanced formation of lipid peroxides and NETs contribute to placental dysfunction and systemic inflammation, exacerbating disease severity. Therapeutic strategies targeting these pathways are emerging but require further validation. Our review also identifies key gaps in mechanistic understanding, biomarker development, and translational research needs. We conclude that modulation of ferroptosis and NETosis offers promising avenues for improving diagnosis and treatment of pregnancy complications, though carefully designed clinical studies are essential to confirm their clinical utility and safety.

23 May 2024 in Genes
Verified
Journal Article
Open access
PDF file
OMOnoufrios Malikides
Onoufrios Malikides
ESEmmanouel Simantirakis
Emmanouel Simantirakis
EZEvangelos Zacharis
Evangelos Zacharis
KFKonstantinos Fragkiadakis
Konstantinos Fragkiadakis
GKGeorge Kochiadakis
George Kochiadakis
Maria E. MarketouMaria E. Marketou
Maria E. Marketou
Cardiac remodeling and ventricular pacing represent intertwined phenomena with profound implications for cardiovascular health and therapeutic interventions. This review explores the intricate relationship between cardiac remodeling and ventricular pacing, spanning from the molecular underpinnings to biomechanical alterations. Beginning with an examination of genetic predispositions and cellular signaling pathways, we delve into the mechanisms driving myocardial structural changes and electrical remodeling in response to pacing stimuli. Insights into the dynamic interplay between pacing strategies and adaptive or maladaptive remodeling processes are synthesized, shedding light on the clinical implications for patients with various cardiovascular pathologies. By bridging the gap between basic science discoveries and clinical translation, this review aims to provide a comprehensive understanding of cardiac remodeling in the context of ventricular pacing, paving the way for future advancements in cardiovascular care.